148 related articles for article (PubMed ID: 15860119)
1. SIV-specific T lymphocyte responses in PBMC and lymphoid tissues of SIV-infected pigtailed macaques during suppressive combination antiretroviral therapy.
Carruth LM; Zink MC; Tarwater PM; Miller MD; Li M; Queen LA; Mankowski JL; Shen A; Siliciano RF; Clements JE
J Med Primatol; 2005 Jun; 34(3):109-21. PubMed ID: 15860119
[TBL] [Abstract][Full Text] [Related]
2. Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.
Shen A; Zink MC; Mankowski JL; Chadwick K; Margolick JB; Carruth LM; Li M; Clements JE; Siliciano RF
J Virol; 2003 Apr; 77(8):4938-49. PubMed ID: 12663799
[TBL] [Abstract][Full Text] [Related]
3. The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy.
Clements JE; Li M; Gama L; Bullock B; Carruth LM; Mankowski JL; Zink MC
J Neurovirol; 2005 Apr; 11(2):180-9. PubMed ID: 16036796
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.
Metzner KJ; Binley JM; Gettie A; Marx P; Nixon DF; Connor RI
Retrovirology; 2006 Dec; 3():97. PubMed ID: 17184540
[TBL] [Abstract][Full Text] [Related]
5. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.
Cranage M; Sharpe S; Herrera C; Cope A; Dennis M; Berry N; Ham C; Heeney J; Rezk N; Kashuba A; Anton P; McGowan I; Shattock R
PLoS Med; 2008 Aug; 5(8):e157; discussion e157. PubMed ID: 18684007
[TBL] [Abstract][Full Text] [Related]
6. Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal.
Van Rompay KK; Trott KA; Jayashankar K; Geng Y; LaBranche CC; Johnson JA; Landucci G; Lipscomb J; Tarara RP; Canfield DR; Heneine W; Forthal DN; Montefiori D; Abel K
Retrovirology; 2012 Jul; 9():57. PubMed ID: 22805180
[TBL] [Abstract][Full Text] [Related]
7. Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.
Van Rompay KK; Johnson JA; Blackwood EJ; Singh RP; Lipscomb J; Matthews TB; Marthas ML; Pedersen NC; Bischofberger N; Heneine W; North TW
Retrovirology; 2007 Apr; 4():25. PubMed ID: 17417971
[TBL] [Abstract][Full Text] [Related]
8. Transient early post-inoculation anti-retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut-associated lymphoid tissues in SIVmac239-infected rhesus macaques, but not resistance to rechallenge.
Lifson JD; Piatak M; Cline AN; Rossio JL; Purcell J; Pandrea I; Bischofberger N; Blanchard J; Veazey RS
J Med Primatol; 2003 Aug; 32(4-5):201-10. PubMed ID: 14498980
[TBL] [Abstract][Full Text] [Related]
9. Development of Vgamma2Vdelta2+ T cell responses during active mycobacterial coinfection of simian immunodeficiency virus-infected macaques requires control of viral infection and immune competence of CD4+ T cells.
Shen L; Shen Y; Huang D; Qiu L; Sehgal P; Du GZ; Miller MD; Letvin NL; Chen ZW
J Infect Dis; 2004 Oct; 190(8):1438-47. PubMed ID: 15378436
[TBL] [Abstract][Full Text] [Related]
10. Simian immunodeficiency virus infection induces severe loss of intestinal central memory T cells which impairs CD4+ T-cell restoration during antiretroviral therapy.
Verhoeven D; Sankaran S; Dandekar S
J Med Primatol; 2007 Aug; 36(4-5):219-27. PubMed ID: 17669210
[TBL] [Abstract][Full Text] [Related]
11. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration.
George MD; Reay E; Sankaran S; Dandekar S
J Virol; 2005 Mar; 79(5):2709-19. PubMed ID: 15708990
[TBL] [Abstract][Full Text] [Related]
12. Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.
Palesch D; Bosinger SE; Mavigner M; Billingsley JM; Mattingly C; Carnathan DG; Paiardini M; Chahroudi A; Vanderford TH; Silvestri G
J Virol; 2018 Jul; 92(14):. PubMed ID: 29720521
[TBL] [Abstract][Full Text] [Related]
13. In vivo blockade of the programmed cell death-1 pathway using soluble recombinant PD-1-Fc enhances CD4+ and CD8+ T cell responses but has limited clinical benefit.
Amancha PK; Hong JJ; Rogers K; Ansari AA; Villinger F
J Immunol; 2013 Dec; 191(12):6060-70. PubMed ID: 24227774
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected Rhesus macaques after short-term antiretroviral treatment.
Spring M; Stahl-Hennig C; Stolte N; Bischofberger N; Heeney J; ten Haaft P ; Tenner-Ràcz K; Ràcz P; Lorenzen D; Hunsmann G; Dittmer U
Virology; 2001 Jan; 279(1):221-32. PubMed ID: 11145904
[TBL] [Abstract][Full Text] [Related]
15. DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued.
Fuller DH; Rajakumar PA; Wu MS; McMahon CW; Shipley T; Fuller JT; Bazmi A; Trichel AM; Allen TM; Mothe B; Haynes JR; Watkins DI; Murphey-Corb M
Virology; 2006 Apr; 348(1):200-15. PubMed ID: 16439000
[TBL] [Abstract][Full Text] [Related]
16. IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques.
Lugli E; Mueller YM; Lewis MG; Villinger F; Katsikis PD; Roederer M
Blood; 2011 Sep; 118(9):2520-9. PubMed ID: 21757617
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in Macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG.
Shen Y; Shen L; Sehgal P; Zhou D; Simon M; Miller M; Enimi EA; Henckler B; Chalifoux L; Sehgal N; Gastron M; Letvin NL; Chen ZW
J Virol; 2001 Sep; 75(18):8690-6. PubMed ID: 11507214
[TBL] [Abstract][Full Text] [Related]
18. CD8+-cell-mediated suppression of virulent simian immunodeficiency virus during tenofovir treatment.
Van Rompay KK; Singh RP; Pahar B; Sodora DL; Wingfield C; Lawson JR; Marthas ML; Bischofberger N
J Virol; 2004 May; 78(10):5324-37. PubMed ID: 15113912
[TBL] [Abstract][Full Text] [Related]
19. Persistent Viral Reservoirs in Lymphoid Tissues in SIV-Infected Rhesus Macaques of Chinese-Origin on Suppressive Antiretroviral Therapy.
Siddiqui S; Perez S; Gao Y; Doyle-Meyers L; Foley BT; Li Q; Ling B
Viruses; 2019 Jan; 11(2):. PubMed ID: 30691203
[TBL] [Abstract][Full Text] [Related]
20. Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques.
Smith MS; Foresman L; Lopez GJ; Tsay J; Wodarz D; Lifson JD; Page A; Wang C; Li Z; Adany I; Buch S; Bischofberger N; Narayan O
Virology; 2000 Nov; 277(2):306-15. PubMed ID: 11080478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
